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Abstract 
Background:  Emergency abdominal surgery carries a high risk of postoperative morbidity 
and mortality.  Goal directed therapy has been advocated to improve outcome in high risk 
surgery.  The aim of the present pilot study was to examine the effect of goal directed therapy 
using fluid alone on postoperative renal function and organ failure score in patients 
undergoing emergency abdominal surgery. 
Methods: This prospective randomized pilot study included patients over the age of 50 
undergoing emergency abdominal surgery. In the intervention group pulse pressure variation 
measurements were used to guide fluid boluses of 6% Hydroxyethylstarch 130/0.4. The 
control group received standard care. Serum urea, creatinine and cystatin C levels were 
measured prior to and at the end of surgery and postoperatively on days 1&3&5. 
Results:   30 patients were recruited.  One patient died prior to surgery and was excluded 
from the analysis. The intervention group received a median of 750 ml of hydroxyethylstarch. 
The peak values of postoperative urea were 6.9 (2.7-31.8) vs 6.4 (3.5-11.5) mmol/l (p=0.425), 
creatinine 100 (60-300) vs 85 (65-150) umol/l (p=0.085) and cystatin C 1.09 (0.66-4.94) vs 
1.01 (0.33-2.29) mg/dl (p=0.352) in the control and intervention group respectively. 
Conclusions:  In the present pilot study replacing the identified fluid deficit was not 
associated with a change in renal function.  These results do not preclude that goal directed 
therapy using fluid alone may have an effect on renal function but they would suggest that the 
effect size of fluid optimization alone on renal function is small. 
 
Keywords: Surgery abdominal, Kidney function, Fluid i.v.
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Introduction 
Despite improvements in surgery and peri-operative care, mortality following emergency 
abdominal surgery remains high with death rates in excess of 20% being reported 
consistently.1 2  Few studies have identified factors which give prognostic information in 
patients undergoing emergency abdominal surgery.  Recognised factors include magnitude of 
surgical insult, admission to intensive care unit, age and ASA status. 2 3  Biondo and 
coworkers reported, that following emergency abdominal surgery, multiple organ failure was 
also important risk factor for 30 day mortality. 4  It is of particular interest that renal failure, as 
indicated by a raised creatinine 5 or urea 3 were associated with an increased 30 day mortality. 
 
Standard treatment for high-risk surgical patients is to maintain cardiovascular parameters 
such as blood pressure, heart rate, central venous pressure and urine output within the normal 
range using fluids initially and inotropic agents if required.  “Goal directed therapy” aims to 
optimise the cardiovascular system and in particular oxygen delivery to support vital organs 
including renal function. 6 - 8   This treatment strategy employs fluids in addition to inotropes 
to achieve this cardiovascular goal.  Although this approach has been associated with a 
reduced 30 day mortality it remained controversial for a number of reasons.  Firstly, it 
involved complex and heterogenous protocols which were difficult to transfer from the 
research stage into clinical practice.  Furthermore, the protocols involved invasive monitoring 
and inotropes and therefore required peri-operative admission to the intensive care unit with 
significant resource implications.  As a consequence implementation of these strategies has 
not been widespread.  Moreover the respective values of fluid optimisation and the provision 
of inotropes is also not well understood. 9   In several studies, in patients undergoing elective 
abdominal surgery, intraoperative optimisation with fluids alone and without the use of 
inotropes, was associated with improved outcomes such as reduced hospital stay and 
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improved gastrointestinal function. 10 - 12  Clearly, if it was shown that in emergency 
abdominal surgery goal directed therapy using fluid alone during the intraoperative period had 
significant value then this simplified low risk approach could then be more readily 
incorporated into clinical practice. 
 
The aim of the present pilot study was to examine the effect of intra-operative goal directed 
therapy using fluid alone on postoperative renal function and organ failure score in patients 
undergoing emergency abdominal surgery. 
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Patients and Methods 
Study setting and patients 
Local research ethics committee approval and written informed consent was obtained for this 
study.  Patients, aged 50 years or over, who were to undergo emergency abdominal surgery at 
the Royal Infirmary, Glasgow between September 2003 and February 2005 were included in 
the study.  Patients were recruited between the hours of 8 am to 8 pm on weekdays.  Those 
patients who presented as an emergency following trauma, were to undergo vascular surgery, 
in whom surgery was expected to last less than 90 minutes or who were on lithium drug 
therapy were excluded from the study. 
 
Study design and randomisation 
Patients eligible for this randomised controlled study were allocated to control and 
intervention arms using opaque sealed envelopes immediately prior to surgery.  The study 
group allocation was not blinded as the control group received no form of study intervention.  
Fluid optimisation was carried out by three investigators (JH, BMcC, AH) none of whom 
were present at the operations in the control group. 
 
Intervention 
In the intervention group an arterial line was sited and connected to the Lidco cardiovascular 
monitor according to manufacturer’s instructions (Lidco plus system, Lidco Ltd., Cambridge, 
UK).  This monitor displays cardiac output, stroke volume, heart rate, systemic vascular 
resistance, systemic oxygen delivery and pulse pressure variations.  Fluid boluses of 250ml of 
6% Hydroxyethylstarch 130/0.4 (Voluven, Fresenius Ltd, Cheshire, UK) were administered 
over 15 minutes during the operation if the pulse pressure varied by more than 10% (modified 
from Michard and colleagues 13).  This was in addition to the normal fluid administration by 
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the anaesthetist in charge of the patient.  Data were recorded manually in 15-minute intervals 
throughout the operation.   
 
The clinical team in charge of the patient in the intervention group did not have access to the 
data provided by the Lidco monitor or the volume of hydroxyethylstarch administered during 
the operation by the research team. 
 
The control group received standard care by the clinical team in charge of the patient without 
the investigator being present in theatre.  The type of anaesthesia in both study arms was at 
the discretion of the anaesthetist in charge of the patient.  At the end of the surgical procedure, 
the pulse contour analysis monitor was disconnected.  Postoperatively both patients, in the 
protocol and intervention group, were managed in the High Dependency or Intensive Care 
Unit and discharged to the ward when clinically deemed appropriate. 
 
Outcome measures 
Urea, creatinine and cystatin C were measured to assess renal function prior to surgery, 
immediately postoperatively, day 1, day 3 and day 5 following surgery.  Arterial and venous 
blood gas samples were measured if an arterial or central venous line was clinically indicated 
(following the induction of anaesthesia (n=22), at the end of surgery (n=25), day 1 (n= 20), 
day 3 (n= 7) and day 5 (n=3)).  The effects of serum electrolytes and weak acids on base 
excess were calculated using the simplified approach as described by Story. 14 
 
The Sequential Organ Failure Assessment (SOFA) score was calculated to assess organ 
function prior to and following surgery on days 1, day 3 and day 5 as described by Vincent 
and coworkers 15.  The score was modified in patients in whom arterial blood gases were not 
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available.  In these patients the PaO2/FiO2 ratio was substituted with the oxygen flow 
required to obtain an oxygen saturation >94 % as follows: score of 0 if < 2 l/min; score of if 
2-3 l/ min; score of 2 if 4-7 l/min; score of 3 if >7 l/min.  
 
The Systemic Inflammatory Response Syndrome (SIRS) score were assessed prior to and 
following surgery on day 1, day 3 and day 5. 16  The Revised Cardiac Risk Index 17 and P-
POSSUM 18 scores were documented immediately before emergency surgery. 
 
The Postoperative Morbidity Survey is validated for patients following elective surgery 
usually associated with a short length of hospital. 19  We modified this score for emergency 
surgery, with a corresponding longer length of hospital stay, by assessing the incidence and 
pattern of postoperative complications on day 5, day 15 and day 30 rather than day 3, day 5 
and day 7.  
 
Mortality at 30 days and length of hospital stay was confirmed from Greater Glasgow Health 
Board.  
 
Statistics 
Data are presented as median (range).  Where appropriate comparisons of data were carried 
out using the chi-square test and Mann Whitney test.  Statistical analysis was performed using 
SPSS software (SPSS Inc., Chicago, Illinois, U.S.A.). 
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Results 
During the study period 153 patients underwent emergency abdominal surgery; of these 19% 
of patients did not meet inclusion criteria of the study.  A further 41 % presented for surgery 
out of hours and 20% could not give informed consent.  30 (20%) patients were recruited into 
the study (Figure 1).  One patient who was randomised to the intervention group died prior to 
surgery and did not receive the intervention.  This patient was excluded from the analysis.   
 
The pre-operative characteristics of the control and intervention groups are shown in Table 1.  
The majority of patients were over the age of 60 years, male, and had Possum (physiological), 
ASA and Lee scores associated with increased risk of peri-operative mortality.  Patient 
characteristics were similar in control and intervention groups. 
 
The intra-operative characteristics of the control and intervention groups are shown in Table 
2.  The site, severity and duration of surgery and anaesthetic technique were similar between 
the groups.  Also the administration of crystalloids, colloids and fluid balance were similar in 
both groups.  The intervention group received a median of 750 ml hydroxyethylstarch.  The 
median central venous pressure (p<0.01) and the hourly urine output (p<0.05) during surgery 
were higher in the intervention group.   
 
At the end of surgery there were no differences in venous blood gases between the control and 
intervention groups.  Both groups had a mild acidosis, normal central venous oxygen 
saturations and normal lactate concentrations. 
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Overall, the surgical Possum score was greater in the intervention group (p<0.05).  This may 
have been due to a trend towards increased blood loss (p=0.377) and peritoneal soiling 
(p=0.177) in the intervention group. 
 
The intra-operative haemodynamic characteristics of the intervention group are shown in 
Table 3.  The data for 2 patients in the intervention was not collected.  Pulse pressure 
variation (p<0.01) was higher, and cardiac output (p< 0.05) and stroke volume (p<0.05) were 
lower following induction of anaesthesia than at the end of surgery.  The haemoglobin 
concentration and oxygen content of blood were lower at the end of surgery than following 
induction of anaesthesia (p< 0.01).  There was no significant difference in oxygen delivery 
between the start and end of surgery.  
 
The peri-operative characteristics of the control and intervention groups during the initial 24 
hours are shown in Table 4.  There were no significant differences in haemodynamic or fluid 
balance data for the groups.  
 
Organ and renal function data in the peri-operative period are shown in Table 5.  In both 
control and intervention groups the SOFA score peaked on day 1.  The peak urea, creatinine 
and cystatin C occurred either pre-operatively or on day 1.  There were no significant 
differences between the control and intervention groups in the peak values of urea (p=0.425), 
creatinine (p=0.085) and cystatin C (p=0.352). 
 
The serum concentrations of albumin, sodium and chloride in the peri-operative period are 
shown in Table 6.  The highest serum sodium and chloride concentrations values were either 
in recovery or on day 1 in both groups.  The trough value for albumin occurred immediately 
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postoperatively.  There were no differences in peak values of serum sodium (p=0.112) and 
chloride (p=0.847) and trough values of albumin (p=0.425) and calculated base deficit 
(p=0.425).  
 
The PMS scores and length of hospital stay data of the control and intervention groups are 
shown in Table 7.  There were no significant differences in the number of patients that 
remained in hospital on day 5 and 30.  On day 15 more patients were in hospital (p<0.05).  
There was a trend towards more complications on day 15 in the intervention group (Table 8). 
There was no difference in overall length of stay (p=0.252).  Also, hospital and 30 day 
mortality was similar in the control and intervention groups.  
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Discussion 
In this randomised controlled pilot study, in patients undergoing emergency abdominal 
surgery, the effect of fluid optimisation alone on renal and organ function was examined.  
Based on increased pulse pressure variations of greater than 10 % we identified a median fluid 
deficit of 750 ml.  However, the correction of the fluid deficit with hydroxyethylstarch was 
not significantly associated with either parameters of improved renal function or with reduced 
complications and hospital stay.  This is, to our knowledge, the first study to examine the 
effect of fluid optimisation alone in patients undergoing emergency abdominal surgery and 
provide baseline information for future fluid alone intervention studies in these patients.  
 
It has long been recognised that organ hypoperfusion has been associated with poorer 
outcome and this has been the basis for using goal directed therapy as a means to optimise 
organ perfusion and oxygen delivery.  A number of workers 6 - 9 have shown that goal directed 
therapy using the combination of fluid and inotropes during the perioperative period reduced 
complications, length of hospital stay and mortality in patients undergoing high risk surgery.  
This effect has mainly been observed in patients undergoing high risk surgery with mortality 
rates in excess of 20%. 20  We have previously shown that, in almost 600 patients between 
1998 and 2000, the 30-day mortality in patients undergoing emergency abdominal surgery 
was 26% and therefore represent a suitable target group for goal directed therapy. 3   
 
In the present study the operative mortality, at 10%, was lower than expected.  The reasons 
for the difference in mortality rates between the two cohorts is not clear. However, this may 
reflect the small sample size.  Alternatively, that 30 day mortality in these patients had 
decreased in the period between the two studies.  Indeed, when we examined the outcome of 
all patients who underwent emergency surgery during the study period (n=153) 30 day 
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mortality was 21%.  This confirms that a relevant high risk cohort was studied but raises the 
issue of why mortality in the experimental group (n=29) was only 10%.  When we examined 
the study patients in detail, it would appear that obtaining consent was more problematical in 
the higher risk patients and that there was a tendency for high risk patients to present for 
surgery out with the daytime recruitment hours.   
 
In this study the primary endpoint was renal function.  In order to assess renal function in 
detail we measured serum urea, creatinine and cystatin C pre-operatively and throughout the 
postoperative period.  Despite this detailed examination of renal function there were no 
differences between the control and intervention groups.  Similarly, there was no beneficial 
effect on organ, gastrointestinal or hospital stay.  The reasons for the lack of therapeutic effect 
of fluid therapy is unclear.  It may be that the therapeutic effect of fluid optimisation is 
relatively small and would not have been detected in the present pilot study.  Indeed, in recent 
randomised studies of elective surgical patients, undergoing fluid optimisation alone, the 
effect on hospital stay was only of the order of 10% to 15%. 10 - 12  This raises the issue of 
whether fluid optimisation alone can produce substantial benefits in the surgical patient.  It is 
also of interest that the initial cardiac output was 5 l/min suggesting that these, and 
presumably also the patients in the control group, were well resuscitated prior to surgery and 
hence the effect size of fluid optimisation would be expected to be relatively small. 
Furthermore, there may be other factors that contribute to the lack of effect observed in this 
study.  Previous studies have identified a therapeutic effect only when the oxygen delivery 
was raised to predefined targets. 6 - 9  It is of interest that in this study, although stroke volume 
and cardiac output increased in response to the fluid therapy, oxygen delivery, as a 
consequence of a decreased oxygen content, did not increase significantly.  This could have 
accounted for the lack of effect seen in this study.  Moreover, hydroxyethylstarch (Voluven), 
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the solution used in this study to optimise the cardiovascular system contains a high chloride 
contents which could result in a hyperchloraemic metabolic acidosis as a consequence of a 
reduced strong ion difference.  Such a metabolic derangement has been associated with 
impaired organ and renal function. 21  It would therefore be possible that the potential 
beneficial effect of fluid optimisation was mitigated by an excessive chloride load.  However, 
there was no evidence of a reduced strong ion difference measured in this study to support 
this explanation.  In summary, the results of this pilot study would suggest that the effect of 
fluid optimisation alone on renal or organ function in well resuscitated patients undergoing 
emergency abdominal surgery is small.  This would therefore indicate that further trials of the 
effect of fluid optimisation alone would not only require much larger cohorts of patients than 
have been studied to date but should also include those high-risk individuals who are 
presenting out of hours or who are unable to give consent for emergency surgery.   
  
Perioperative fluid therapy is part of routine care.  However, the optimal fluid strategy is 
unclear.  It has long been recognised that fluid overload appears to be associated with 
increased complications and a prolonged hospital stay. 22  It is of interest that  perioperative 
restriction of fluids was associated with improved outcome in some studies 23-25 but not 
others. 26  Taken together the results of studies examining fluid balance in high risk surgical 
patients would suggest that fluid should only be given to those patients with proven fluid 
deficit.  However, the best method to demonstrate a fluid deficit in surgical patients is unclear.  
A number of workers 10-12 have examined the use of oesophageal Doppler guided fluid 
therapy during the intra-operative period in patients undergoing high risk surgery.  In these 
studies fluid alone was associated with fewer complications, in particular gastrointestinal 
complications, and reduced length of hospital stay.  However, when using this monitor we 
found that artefacts, in particular resulting from diathermy, which is extensively used 
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abdominal surgery, limited the usefulness of this device.  More recently, pulse pressure 
variation in response to mechanical ventilation has been advocated to assess fluid volume 
status. 13  This technique has a number of advantages; it is simple to use, non-invasive and in 
addition this technology is free from interference by diathermy.  Our study is the first to show 
that this method is a feasible approach to intraoperatively assessing fluid balance.  We chose a 
pulse pressure variation of more than 10% as the trigger for the administration of a bolus.  
The optimal trigger is unknown.  Previous work has identified patients to be fluid responsive 
if pulse pressure variation varied by more than 13%. 13  In the present study the volume of 
fluid administered was higher than described in previous work (750 ml vs <  500ml) using the 
oesophageal Doppler monitor.  It is of interest that in the intervention group of the present 
study a larger proportion of patients was in hospital on day 15 and there was a trend towards 
increased postoperative complications in the intervention group.  It is therefore possible that a 
low threshold trigger could have led to excessive fluid administration and therefore be related 
to the trend towards prolonged hospitalisation.  Further work is required to identify the 
optimal trigger for intraoperative fluid administration when using pulse pressure variation.  
 
Limitations of the present study include the small number of patients recruited in a single 
centre.  Nevertheless this is to our knowledge the largest study of fluid optimisation in 
patients undergoing emergency abdominal surgery.  The study included patients undergoing a 
wide spectrum of clinical problems which was managed by varying anaesthetic and surgical 
staff.  As a consequence of this it was unfeasible to standardise clinical management which 
resulted in larger variability of clinical care and this could have mitigated the potential effect 
of the intervention.  The present study, although not fully blinded, was randomised and the 
collection of the postoperative data was carried out by an investigator (JEMC) who was 
unaware of the patient allocation.  Furthermore, in order to minimise the potential bias in the 
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intervention group the additional haemodynamic data and volume of hydroxyethylstarch 
administered was concealed from the clinical team in charge of the patient.  Clearly, in the 
control group the absence of additional cardiovascular monitoring reduced potential bias but 
also meant that no comparative intraoperative haemodynamic data could be recorded.  
 
In summary, the results of the present pilot study show that fluid optimisation based on pulse 
pressure variation is feasible and identified a fluid deficit in patients undergoing emergency 
abdominal surgery.  However, replacing such fluid was not associated with an improvement 
in renal or organ function. Although these results do not preclude that goal directed therapy 
using fluid alone may have an effect on renal function following emergency abdominal 
surgery, they would however suggest that the effect size of this intervention on renal function 
is small.  Fluid optimisation was also associated with a prolongation of hospital stay and a 
trend towards increased complications that may be related to excessive volume of fluid.  
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Table 1.  Pre-operative characteristics of control and intervention groups in patients 
undergoing emergency abdominal surgery (n=29) 
 
 Control (n=15) Intervention (n=14) p-value 
Age (years) 64 (51-76) 66 (56-75) 0.377 
Gender (female/male) 3/12 3/11 0.666 
BMI 26 (18-38) 23 (17-37) 0.172 
    
POSSUM (physiological) 18 (13-40) 22 (13-44) 0.189 
ASA 3 (1-4) 3 (1-4) 0.937 
LEE 3 (2-4) 3 (2-4) 0.589 
SOFA 1 (0-3) 1 (0-6) 0.399 
SIRS 1 (0-4) 1.5 (0-4) 0.467 
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Table 2.  Intra-operative characteristics of control and intervention groups in patients 
undergoing emergency abdominal surgery (n=29) 
 Control (n=15) Intervention (n=14) p-value 
Type of surgery    
Duodenal ulcer repair 1 1  
Small bowel resection 3 2  
Choelcystectomy 1 1  
Large bowel resection 9 8  
Others 1 2  
Duration of surgery (mins) 120 (45-240) 100 (40-295) 0.497 
Epidural catheter (yes/no) 6/9 7/7 0.588 
CVP (yes/no) 14/1 10/4 0.119 
IBP (yes/no) 12/3 (14/0) 0.077 
Crystalloids (ml) 2000 (0-4000) 1750 (1000-3500) 0.947 
Intraop inotropic support 1 1 1.0 
Colloids (ml) 1000 (0-3500) 1000 (0-3000) 0.627 
Hydroxyethylstarch (ml) 0 750 (0-1750) <0.001 
Fluid balance (ml) 1910 (-280 to 4543) 1515 (-650 to3250) 0.481 
Blood loss 250 (0-750) 400 (0-2000) 0.172 
Haemoglobin    
   Postinduction 10.7 (6.8-16.0) 11.1 (6.9-14.0) 0.838 
   End of operation 10.7 (7.4-13.5) 8.6 (6.9-13.5) 0.095 
CVP highest (mmHg) 9 (0-12) 13 (9-17) 0.002 
BP mean lowest (mmHg) 59.9 (46.5-83.2) 61.8 (39.9-93.2) 0.949 
HR highest (beats/minute) 100 (80-120) 100 (70-120) 0.715 
Urine output (ml/hr) 69 (0-333) 109 (57-393) 0.014 
Temperature lowest (C) 36.5 (35.7-37.8) 36.4 (34.8-37.9) 0.576 
End of Surgery VBGs    
   H+ (nmol/l) 47.0 (41.0-65.0) 49.4 (39.0-55.0) 0.910 
   BE (mmol/l) -0.10 (-8.0 - 7.0) -3.0 (-7.0 - 2.0) 0.616 
   CV SpO2 (%) 74.0 (54.0 - 83.0) 74.6 (65.0-89.0) 0.793 
   Lactate (mmol/l) 1.4 (0.6 - 4.0) 1.2 (0.7 - 2.0) 0.319 
Possum (surgical) 15 20 0.014 
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VBGs Venous blood gas sample,  
CVP =central venous pressure monitoring, IBP=invasive arterial pressure monitoring 
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Table 3. Haemodynamic characteristics in the intervention group at postinduction and at the 
end of surgery. 
 Postinduction 
(n=12) 
End of Surgery 
(n=12) 
p-value 
Pulse Pressure Variation (%) 14.0 (3.3-33.0) 6.6 (3.3-14.5) 0.005 
Cardiac Output (l/min) 5.05 (3.2-12.6) 5.95 (3.2-12.6) 0.023 
Stroke Volume (ml) 72.0 (44.0-137.0) 82.0 (43.0-136.0) 0.030 
Haemoglobin (g/dl) 11.1 (6.9-14.0) 8.6 (6.9-13.5) 0.007 
Oxygen content (ml/l) 147.6 (105.5-178.4) 119.3 (95.2-176.4) 0.007 
Oxygen delivery (ml/min/m2) 352.5 (251.0-925.0) 440 (197-918) 0.799 
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Table 4. Immediate postoperative (24 hours) haemodynamic and fluid balance data of control 
and intervention groups in patients undergoing emergency abdominal surgery (n=29). 
 
 Control (n=15) Intervention (n=14) p-value 
Crystalloids (ml) 3100 (2200-4000) 3687 (1500-7500) 0.235 
Colloids (ml) 0 (0-2250) 0 (0-1500) 0.403 
Fluid balance (ml) 2055 (500 to 6205) 2935 (610 to 9570) 0.105 
CVP lowest (mmHg) 1 (-3 to12) 2 (-4 to 6) 0.979 
BP mean lowest (mmHg) 63.1 (49.9-89.9) 63.1 (50.2-91.2) 0.892 
HR highest (beats/minute) 100 (70-126) 100 (70-125) 0.821 
Urine output (ml/hr) 20 (0-50) 20 (0-50) 0.339 
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Table 5.  Peri-operative organ function scores and renal function parameters of control and 
intervention groups in patients undergoing emergency abdominal surgery (n=29). 
 
Control 
(n=15) 
SOFA SIRS Urea 
(mmol/l) 
Creatinine 
(umol/l) 
Cystatin C 
 (mg/dl) 
Preop 1 (0-3) 1 (0-4) 5.6 (2.3-30.0) 100 (70-260) 1.19 (0.74-3.95) 
Recovery   5.2 (2.1-28.1) 95 (60-280) 0.99 (0.59-3.73) 
Day 1 3 (0-10) 2 (0-4) 6.7 (2.2-31.8) 95 (60-300) 0.91 (0.71-4.94) 
Day 3 2 (0-10) 2 (0-4) 3.8 (1.6-24.0) 80 (55-300) 0.91 (0.61-4.41) 
Day 5 1 (0-5) 1 (0-3) 4.4 (2.1-23.8) 75 (37-260) 0.96 (0.69-3.64) 
 
     
Intervention 
(n=14) 
SOFA SIRS Urea 
(mmol/l) 
Creatinine 
(umol/l) 
Cystatin C 
(mg/dl) 
Preop 1 (0-6) 1 (0-4) 6.4 (2.3-12.3) 85 (55-160) 0.87 (0.64-2.48) 
Recovery   5.2 (2.8-9.8) 77 (60-140) 0.8 (0.47-2.10) 
Day 1 3 (1-4) 2 (0-4) 5.7 (3.5-10.5) 85 (60-150) 1.01 (0.63-2.29) 
Day 3 2 (0-4) 1 (0-4) 4.2 (1.3-10.3) 68 (50-110) 0.86 (0.39-1.72) 
Day 5 1 (0-3) 1 (0-2) 3.1 (1.2-11.9) 75 (43-140) 0.85 (0.53-1.52) 
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Table 6. Peri-operative albumin, electrolytes and calculated base deficit of control and 
intervention groups in patients undergoing emergency abdominal surgery (n=29). 
 
Control 
(n=15) 
Albumin  
(g/l) 
Sodium 
(mmol/l) 
Chloride 
(mmol/l) 
BDENacl+ Albumin 
Preop 36 (19-47) 138 (130-142) 102 (84-108) -0.5 (-9.5 to 7.8) 
Recovery 24 (11-40) 140 (134-145) 107 (95-115) 0.8 (-6.5 to 8.3) 
Day 1 26 (13-48) 140 (132-146) 104 (100-111) 1.8 (-4 to 6.3) 
Day 3 28 (15-34) 139 (133-146) 102 (99-114) 2.0 (-3.3 to 10.3) 
Day 5 28 (17-35) 139 (134-150) 105 (97-116) 1.8 (-2.3 to 6.3) 
 
   
 
Intervention 
(n=14) 
Albumin  
(g/l) 
Sodium 
(mmol/l) 
Chloride 
(mmol/l) 
BDENacl+ Albumin 
Preop 37 (16-43) 137 (132-142) 100 (95-109) 1.0 (-7.3 to 7.5) 
Recovery 20 (13-28) 140 (130-144) 104 (100-112) 0.5 (-6.5 to 11.5) 
Day 1 21 (15-35) 140 (133-146) 106 (97-114) -0.1 (-6.8 to 5.0) 
Day 3 26 (21-35) 139 (130-144) 102 (99-111) 2.3 (-6.0 to 5.8) 
Day 5 27 (21-36) 138 (132-144) 101 (89-107) 2.5 (-3.8 to 12.7) 
 
BDENacl+ Albumin=calculated Base deficit (Story 2004)  
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Table 7.  Post-operative characteristics of control and intervention groups in patients 
undergoing emergency abdominal surgery (n=29). 
 
    
Hospital stay (days) 12 (7-55) 17.5 (7-41) 0.122 
ITU (yes/no) 4/11 5/10 0.690 
HDU (yes/no) 14/1 14/0 0.326 
30 day mortality (alive/dead) 13/2 13/1 0.584 
 
PMS =postoperative morbidity score, ITU=intensive care unit, HDU=high dependency unit 
 Control  Intervention p-value 
PMS Day 5 3 (0-6) 3 (0-6) 0.982 
In hospital (yes/no) 15/0 14/0 1.000 
PMS Day 15 0 (0-5) 1 (0-7) 0.328 
In hospital (yes/no) 4/11 9/5 0.042 
PMS Day 30 0 (0-1) 0 (0-1) 1.000 
In hospital (yes/no) 1/12 1/12 1.000 
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Table 8.  Characteristics of post-operative morbidity score (day 15) of control and 
intervention groups in patients undergoing emergency abdominal surgery (n=29). 
 
 Control  Intervention p-value 
Pulmonary (yes/no) 2/13 2/12 0.941 
Infection (yes/no) 4/11 3/11 0.742 
Renal (yes/no) 2/13 5/9 0.159 
Gastrointestinal (yes/no) 1/14 4/10 0.119 
Cardiovascular (yes/no) 1/14 1/13 0.960 
Neuro (yes/no) 0/15 2/12 0.129 
Wound (yes/no) 2/13 1/13 0.584 
Haematology (yes/no) 0/15 1/13 0.292 
Pain (yes/no) 2/13 1/13 0.584 
Total number of patients with 
complications (yes/no) 
 
4/11 
 
7/7 
 
0.196 
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Figure 1 Flow chart of  patients presenting for emergerncy abdominal surgery 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
  
 
 
TOTAL NUMBER OF 
LAPAROTOMIES 
N=153 
 
ELIGIBLE LAPAROTOMIES 
N=124 
 
TOTAL NUMBER OF 
LAPAROTOMIES 
SUITABLE FOR CONSENT 
N=60 
 
TOTAL NUMBER OF 
LAPAROTOMIES 
RANDOMISED 
N=30 
 
ANALYSED 
LAPAROTOMIES 
N=29 
Patient died prior to surgery (n=1) 
 
Consent not possible due to incapacity (n=30) 
 
Out of hours presentation (n=64) 
 
Did not meet inclusion criteria (n=29) 
 
